Aurora Therapeutics has officially launched with a $16 million seed financing from Menlo Ventures. Founded by CRISPR pioneers Jennifer Doudna and Fyodor Urnov, the company aims to address rare genetic mutations at scale. Their platform will leverage modular gene editors and new regulatory pathways. This funding will help transform personalized gene editing into a scalable model for millions of patients.
Company Information
Company
Aurora Therapeutics
Location
Boston, Massachusetts, United States
About
Aurora Therapeutics is a biotechnology company focused on developing personalized gene editing therapies for patients with rare diseases. Founded by CRISPR pioneers Jennifer Doudna and Fyodor Urnov, the company aims to transform this technology into a scalable model that can treat many patients simultaneously. Aurora leverages modular gene editors and innovative regulatory strategies to address rare genetic mutations that have historically been difficult to treat. The company is dedicated to bringing advancements in gene editing to a broader population of patients in need.
Fundz sees it the moment Aurora Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonBiotechnologyHealth CareGeneticsTherapeutics